Silymarin effects on intracellular calcium and cytotoxicity:: A study in perfused rat hepatocytes after oxidative stress injury

被引:60
作者
Farghali, H [1 ]
Kameniková, L [1 ]
Hynie, S [1 ]
Kmonicková, E [1 ]
机构
[1] Charles Univ Prague, Fac Med 1, Inst Pharmacol, Prague 12800 2, Czech Republic
关键词
silymarin; tert-butylhydroxide D-galactosamine; perfused hepatocytes;
D O I
10.1006/phrs.1999.0575
中图分类号
R9 [药学];
学科分类号
1007 [药学];
摘要
The re-emergence of silymarin as a natural remedy for diseases of the liver and biliary tract necessitates revaluation of the efficiency of this compound and its possible mode of action. The aim of this study was to investigate the potentials of silymarin on the amelioration of hepatic injuries. The possible mechanism(s) that contribute to the hepatoprotective effect of silymarin and the role played by intracellular calcium (Ca-i(2+)) was investigated using tert-butyl hydroperoxide (TBH) and D-galactosamine (D-Gal) intoxication in a model of the isolated immobilized and perfused hepatocytes. Silymarin decreased lactate dehydrogenase (LDH) leakage, increased oxygen consumption, reduced the formation of lipid peroxides (malondialdehyde, MDA) in hepatocytes that were altered by TBH and increased urea synthesis in the perfusion medium. TBH treatment increased Ca-i(2+) in hepatocytes significantly to a value of more than 600 nM and silymarin pre-treatment reduced the TBH-induced rise in Ca-i(2+) and brought Ca-i(2+) level to below 300 nM. Silymarin did not affect LD leakage or urea synthesis in D-Gal-injured cells. It is concluded that silymarin hepatoprotective effect under the present experimental conditions is due to the inhibition of lipid peroxidation and that the modulation of hepatocyte Ca-i(2+) plays a pivotal role in a protective effect. (C) 2000 Academic Press.
引用
收藏
页码:231 / 237
页数:7
相关论文
共 33 条
[1]
AHMAD N, 1988, BIOCHEM BIOPH RES CO, V247, P294
[2]
Berry M.N., 1991, ISOLATED HEPATOCYTES, P15, DOI DOI 10.1016/S0075-7535(08)70023-8
[3]
BOARI C, 1981, DRUG EXP CLIN RES, V7, P115
[4]
Silymarin retards collagen accumulation in early and advanced biliary fibrosis secondary to complete bile duct obliteration in rats [J].
Boigk, G ;
Stroedter, L ;
Herbst, H ;
Waldschmidt, J ;
Riecken, EO ;
Schuppan, D .
HEPATOLOGY, 1997, 26 (03) :643-649
[5]
EFFECT OF THE FLAVANOLIGNANS OF SILYBUM-MARIANUM L ON LIPID-PEROXIDATION IN RAT-LIVER MICROSOMES AND FRESHLY ISOLATED HEPATOCYTES [J].
BOSISIO, E ;
BENELLI, C ;
PIROLA, O .
PHARMACOLOGICAL RESEARCH, 1992, 25 (02) :147-154
[6]
LIPID-PEROXIDATION AND IRREVERSIBLE DAMAGE IN THE RAT HEPATOCYTE MODEL - PROTECTION BY THE SILYBIN PHOSPHOLIPID COMPLEX IDB-1016 [J].
CARINI, R ;
COMOGLIO, A ;
ALBANO, E ;
POLI, G .
BIOCHEMICAL PHARMACOLOGY, 1992, 43 (10) :2111-2115
[7]
FARGHALI H, 1984, METHOD FIND EXP CLIN, V6, P449
[8]
FARGHALI H, 1977, METHODS BIOTECHNOLOG, P175
[9]
FEHER J, 1989, Orvosi Hetilap, V130, P2723
[10]
RANDOMIZED CONTROLLED TRIAL OF SILYMARIN TREATMENT IN PATIENTS WITH CIRRHOSIS OF THE LIVER [J].
FERENCI, P ;
DRAGOSICS, B ;
DITTRICH, H ;
FRANK, H ;
BENDA, L ;
LOCHS, H ;
MERYN, S ;
BASE, W ;
SCHNEIDER, B .
JOURNAL OF HEPATOLOGY, 1989, 9 (01) :105-113